Showing results (1-10 of 195) with videos related to
Sort By:
Pageof 20
Clinical Immunology (Orlando, Fla.)|November 1, 2005
HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia)Marla M Vacek, Alejandro A Schäffer, Joie Davis, et al.Current Opinion in Allergy and Clinical Immunology|November 9, 2007
Neonatal screening for severe combined immune deficiencyJennifer M PuckThe Journal of Allergy and Clinical Immunology|January 31, 2012
Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circlesJennifer M PuckThe Journal of Allergy and Clinical Immunology|October 13, 2007
Population-based newborn screening for severe combined immunodeficiency: steps toward implementationJennifer M Puck, Immunologic Research|October 6, 2007
Severe combined immunodeficiency: new advances in diagnosis and treatmentJennifer M PuckThe Hastings Center Report|August 23, 2018
Lessons for Sequencing from the Addition of Severe Combined Immunodeficiency to Newborn Screening PanelsJennifer M PuckImmunological Reviews|December 20, 2018
Newborn screening for severe combined immunodeficiency and T-cell lymphopeniaJennifer M PuckAnnals of the New York Academy of Sciences|January 13, 2012
The case for newborn screening for severe combined immunodeficiency and related disordersJennifer M PuckCurrent Opinion in Pediatrics|October 18, 2011
Neonatal screening for severe combined immunodeficiencyJennifer M PuckClinical Immunology (Orlando, Fla.)|July 26, 2002
Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndromeFrederick D Goldman, Rajeev Vibhakar, Jennifer M Puck, et al.Pageof 20